RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
CTT Pharmaceutical Holdings Stock

CTT Pharmaceutical Holdings Debt 2024

CTT Pharmaceutical Holdings Debt

0 USD

Ticker

CTTH

ISIN

US12651E1064

WKN

A14ZP5

In 2024, CTT Pharmaceutical Holdings's total debt was 0 USD, a 0% change from the 0 USD total debt recorded in the previous year.

CTT Pharmaceutical Holdings Aktienanalyse

What does CTT Pharmaceutical Holdings do?

CTT Pharmaceutical Holdings Inc. is a leading company in the pharmaceutical industry specializing in the development, manufacturing, and marketing of various cannabis-based products. It was founded in 2007 as a research company focused on the medical applications of cannabis. In 2014, the company received patents for their revolutionary platform technology for delivering cannabinoids through lozenges. CTT's business model is based on the development and commercialization of patented delivery systems for cannabinoids, primarily focusing on lozenges. It has subsidiaries and joint ventures in countries like the US, Mexico, and Australia. CTT aims to be a leading provider of cannabinoid-based medicines, with a focus on pain management, neurological disorders, and cancer treatment. Some of their key products include CannavertTM for chemotherapy-induced nausea and vomiting, OraldissTM for neurological conditions like epilepsy and Parkinson's disease, and AnesthevertTM for acute and chronic pain management. CTT collaborates with other pharmaceutical companies and research institutions to market their products and improve their technology. CTT Pharmaceutical Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding CTT Pharmaceutical Holdings's Debt Structure

CTT Pharmaceutical Holdings's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing CTT Pharmaceutical Holdings's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to CTT Pharmaceutical Holdings’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in CTT Pharmaceutical Holdings’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about CTT Pharmaceutical Holdings stock

What is the debt of CTT Pharmaceutical Holdings this year?

CTT Pharmaceutical Holdings has a debt level of 0 USD this year.

What was the debt of CTT Pharmaceutical Holdings compared to the previous year?

The debt of CTT Pharmaceutical Holdings has increased by 0% compared to the previous year dropped.

What are the consequences of high debt for investors in CTT Pharmaceutical Holdings?

High debt can pose a risk for investors of CTT Pharmaceutical Holdings, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of CTT Pharmaceutical Holdings?

Low debt means that CTT Pharmaceutical Holdings has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from CTT Pharmaceutical Holdings affect the company?

An increase in debt of CTT Pharmaceutical Holdings can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of CTT Pharmaceutical Holdings affect the company?

A reduction in debt of CTT Pharmaceutical Holdings can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of CTT Pharmaceutical Holdings?

Some factors that can influence the debt of CTT Pharmaceutical Holdings include investments, acquisitions, operating costs, and revenue development.

Why are the debts of CTT Pharmaceutical Holdings so important for investors?

The debts of CTT Pharmaceutical Holdings are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can CTT Pharmaceutical Holdings take to change the debt?

To change the debt, CTT Pharmaceutical Holdings can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does CTT Pharmaceutical Holdings pay?

Over the past 12 months, CTT Pharmaceutical Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, CTT Pharmaceutical Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of CTT Pharmaceutical Holdings?

The current dividend yield of CTT Pharmaceutical Holdings is .

When does CTT Pharmaceutical Holdings pay dividends?

CTT Pharmaceutical Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of CTT Pharmaceutical Holdings?

CTT Pharmaceutical Holdings paid dividends every year for the past 0 years.

What is the dividend of CTT Pharmaceutical Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is CTT Pharmaceutical Holdings located?

CTT Pharmaceutical Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von CTT Pharmaceutical Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CTT Pharmaceutical Holdings from 10/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/27/2024.

When did CTT Pharmaceutical Holdings pay the last dividend?

The last dividend was paid out on 10/27/2024.

What was the dividend of CTT Pharmaceutical Holdings in the year 2023?

In the year 2023, CTT Pharmaceutical Holdings distributed 0 USD as dividends.

In which currency does CTT Pharmaceutical Holdings pay out the dividend?

The dividends of CTT Pharmaceutical Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von CTT Pharmaceutical Holdings

Our stock analysis for CTT Pharmaceutical Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CTT Pharmaceutical Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.